CAM
HCAT icon

Cresset Asset Management’s Health Catalyst HCAT Stock Holding History

Cresset Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.5K Hold
10,605
– – ﹤0.01% 1605
2025
Q4 		$25.3K Hold
10,605
– – ﹤0.01% 1638
2025
Q3 		$30.2K Buy
+10,605
New +$36.3K ﹤0.01% 1544

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cresset Asset Management's HCAT Position: Q1 2026 in Review

Cresset Asset Management held its Health Catalyst (HCAT) position steady in Q1 2026 at 10,605 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1605.

Cresset Asset Management first reported a position in HCAT in Q3 2025 and has held it in 3 quarters since. The position peaked at $30.2K in Q3 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Cresset Asset Management held 10,605 shares of Health Catalyst worth $13.5K as of Q1 2026.
  • Cresset Asset Management left its Health Catalyst share count unchanged in Q1 2026.
  • Health Catalyst made up ﹤0.01% of Cresset Asset Management's portfolio in Q1 2026, its #1605 holding.
  • Cresset Asset Management first reported a position in Health Catalyst in Q3 2025 and has held it in 3 quarters since.
  • Cresset Asset Management's Health Catalyst position peaked at $30.2K in Q3 2025.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.